Daily Spotlight: Payrolls Power Higher

Is ABBV a good stock to buy? We came across a bullish thesis on AbbVie Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ABBV. AbbVie Inc.’s share was trading at…

Eli Lilly chief scientific and product officer Daniel Skovronsky discusses FDA approval of its new oral GLP-1 drug, a $4.5B manufacturing expansion and Mounjaro becoming the world’s top-selling drug on ‘Mornings with Maria.’ Cups of…

Eli Lilly and Co. (NYSE:LLY) on Wednesday shared topline results from the landmark TOGETHER-PsO open-label Phase 3b trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) compared to Taltz alone for plaque psoriasis and…